|
Neuro Therapeutics Inc. About Neuro Therapeutics Inc. Nti Has Developed Two New Proprietary Technologies That Target G-protein Coupled Receptors (Gpcrs). Gpcrs Have Long Proven To Be Clinically Relevant Drug Targets. They Account For Nearly Half Of All The Pharmaceutical Drugs On The Market And Drugs...
Site: www.neurotherapeutics.com
No extra data was crawled from this site |
Submit Your Site
|
Close this Window
|